Company profilePharmaceutical#751 of 1,318 in Pakistan✓ No DRAP alerts

BIOSYNTH PHARMA (PVT) LTD.

Pharmaceutical company · 11 brands · 16 molecules

Ranked #41 of 58 companies in Skin Conditions

11 registered products 14 pharmaceutical brands 16 distinct molecules 0 DRAP alerts

Company overview

11
registered products
14
pharmaceutical brands
16
distinct molecules
1
therapeutic classes
0
DRAP alerts

BIOSYNTH PHARMA (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 11 product registrations across 16 distinct molecules. Its portfolio is concentrated in Skin Conditions. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by BIOSYNTH

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Glycerin2 brands
Boric Acid2 brands
Ephedrine1 brand
Menthol1 brand
Sodium1 brand
Kaolin1 brand
Paraffin1 brand

Therapeutic classes

Skin Conditions · 1

Conditions treated

Infection/Allergy · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO2 products · Rs 73.09 – Rs 522.51
Servaid2 products · Rs 31 – Rs 150
Median across source: Rs 297.8

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

EFROZE CHEMICAL INDUSTRIES (PVT) LTD. holds 47 molecules not in this portfolio
Aluminium HydroxideAluminium Hydroxide And OxideAspirinBisoprololCastor OilCelecoxib
REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD. holds 68 molecules not in this portfolio
AcetazolamideAcyclovirAmlodipineAmoxicillinAmoxycillin BaseArtemether
KRKA-PAK PHARMACEUTICAL & CHEMICAL WORKS holds 34 molecules not in this portfolio
AmlodipineArtemetherAzithromycinAzithromycin UspBupivacaineCefixime

Get the full profile for BIOSYNTH

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.